Podcast

From Volunteer to Patient to Advocate: How a Breast Cancer Survivor’s Life Has Changed Over the Years

A woman without a family history of breast cancer shares how she went from volunteering at breast cancer walks to one day finding herself in the shoes of someone living with the disease.

Kelly Thomas wasn’t expecting to be on this side of the breast cancer experience.

Thomas worked in finance and the company she was employed at regularly partnered with the American Cancer Society. Throughout the years, she routinely volunteered to collect donations for the American Cancer Society during breast cancer walks.

Despite not having a family history of breast cancer, she remained diligent about self-exams but never noticed anything. Everything changed one December morning in 2017, when she sat down to watch TV and felt a large lump on her left breast. Thomas, who was 33 at the time, immediately made an appointment to see her gynecologist who then referred her to get a mammogram.A week later, she was diagnosed with stage 3 triple-negative breast cancer.

In today’s episode of the “Cancer Horizons” podcast, Thomas breaks down her journey from volunteer to patient to advocate, the isolation she felt navigating breast cancer as a younger woman, starting an Instagram account to promote positive stories of patients living with triple-negative breast cancer and more.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer.
Dr. Debu Tripathy is a professor and chairman of the Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, in Houston, and the editor-in-chief of CURE®.
Dr. John Oertle discusses the key benefits to come from patients with cancer connecting with support networks, advocacy groups and resources.
Dr. Gabriel A. Brooks discussed the recent FDA product labeling update for Xeloda and 5-FU.
Dr. Azka Ali is a medical oncologist at the Cleveland Clinic Taussig Cancer Institute, in Ohio.
Dr. Maxwell Lloyd, a Clinical Fellow in Medicine in the Department of Medicine at Beth Israel Deaconess Medical Center in Boston.
Photo credit: Max Mumby/Indigo via Getty Images
Dr. Maxwell Lloyd, a Clinical Fellow in Medicine, in the Department of Medicine, at Beth Israel Deaconess Medical Center in Boston.
Dr. Aditya Bardia is a professor in the Department of Medicine, Division of Hematology/Oncology, director of Translational Research Integration, and a member Signal Transduction and Therapeutics, at University of California, Los Angeles (UCLA) Health Jonsson Comprehensive Cancer Center.
Image of a woman with light shoulder-length hair, wearing rectangular glasses.
Related Content